Home  »  Companies   »  Evogene Ltd. (NASDAQ: EVGN) Offers Great Upside...

Evogene Ltd. (NASDAQ: EVGN) Offers Great Upside

Evogene Ltd. (NASDAQ:EVGN) shares, rose in value on Friday, 08/05/22, with the stock price down by -8.11% to the previous day’s close as strong demand from buyers drove the stock to $1.02.

Actively observing the price movement in the last trading, the stock closed the session at $1.11, falling within a range of $0.9608 and $1.10. The value of beta (5-year monthly) was 0.96. Referring to stock’s 52-week performance, its high was $3.58, and the low was $0.68. On the whole, EVGN has fluctuated by 34.21% over the past month.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.17, which is expected to increase to -$0.15 for fiscal year -$0.67 and then to about -$0.67 by fiscal year 2022.

Analysts have estimated the company’s revenue for the quarter at $270k, with a low estimate of $200k and a high estimate of $340k. Wall Street analysts also predicted that in 2022, the company’s y-o-y revenues would reach $1.18 million, representing an increase of 13.50% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that EVGN’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Sell while long term indicators on average have been pointing out that it is a 50% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of EVGN currently trading nearly 17.41% and 20.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.51, while the 7-day volatility ratio is showing 10.78% which for the 30-day chart, stands at 11.24%. Furthermore, Evogene Ltd. (EVGN)’s beta value is 1.36, and its average true range (ATR) is 0.10.

A comparison of Evogene Ltd. (EVGN) with its peers suggests the former has fared considerably weaker in the market. EVGN showed an intraday change of -8.11% in last session, and over the past year, it shrunk by -63.04%%. In comparison, 22nd Century Group Inc. (XXII) has moved higher at 5.24% on the day and was down -42.90% over the past 12 months. On the other hand, the price of Compugen Ltd. (CGEN) has fallen -5.81% on the day. The stock, however, is off -79.41% from where it was a year ago. Other than that, the overall performance of the S&P 500 during the last trading session shows that it lost -0.16%. Meanwhile, the Dow Jones Industrial Improved by 0.23%.

Data on historical trading for Evogene Ltd. (NASDAQ:EVGN) indicates that the trading volumes over the past 10 days have averaged 0.11 million and over the past 3 months, they’ve averaged 133.29K. According to company’s latest data on outstanding shares, there are 41.19 million shares outstanding.

Nearly 6.11% of Evogene Ltd.’s shares belong to company insiders and institutional investors own 6.70% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.27 million shares as on Jul 14, 2022, resulting in a short ratio of 2.73. According to the data, the short interest in Evogene Ltd. (EVGN) stood at 0.65% of shares outstanding as of Jul 14, 2022; the number of short shares registered in Jun 14, 2022 reached 0.38 million. The stock has fallen by -37.80% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EVGN stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]